Home
About
FAQ
History (4)
"Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents.
Albuminuria: is it time to screen the general population?
Gangliosidoses, GM2
Plasma amyloid beta 40/42, phosphorylated tau 181, and neurofilament light are associated with cognitive impairment and neuropathological changes among World Trade Center responders: A prospective cohort study of exposures and cognitive aging at midlife.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Albuminuria: is it time to screen the general population?
Crews DC, Boulware LE, Gansevoort RT, Jaar BG. Albuminuria: is it time to screen the general population? Adv Chronic Kidney Dis. 2011 Jul; 18(4):249-57.
View in:
PubMed
subject areas
Albuminuria
Cardiovascular Diseases
Female
Humans
Kidney Diseases
Male
Mass Screening
Risk Factors
Sensitivity and Specificity
Urinalysis
authors with profiles
Leigh E. Boulware MD, MPH